Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific Group Attends the Stem Cell Conference.


SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG) attended the Stem Cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 Conference. The conference represented the initial roll-out of Proposition 71, which was approved by California voters creating a $3 billion fund for stem cell research last November.

Bio-Matrix Scientific Group's President Brian Pockett was one of the Company's attendees. Mr. Pockett said, "The conference was exciting, unveiling California's plans for stem cell research grants. Everyone there was enthusiastic about the future." Mr. Pockett noted that Proposition 71 calls for making $295 million available for stem cell researchers every year for next 10 years.

The California Institute for Regenerative Medicine The California Institute for Regenerative Medicine (CIRM) was created by California's Proposition 71 (2004), which authorized it to issue $3 billion in grants, funded by bonds, over ten years for embryonic stem cell and other biomedical research.  hopes to have the first grants in place to companies by May 2005. Grant money will be available for Embryonic Research, Adult Stem Cell Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body  Research, Research Devices and for building Research Labs in the State of California.

Bio-Matrix Scientific will be applying for grants for its Stem Cell Research and Research Devices. Dr. Philip Watts, Director of Research and Development, will be heading up the team of researchers for Bio-Matrix Scientific.

Scientists have stated that stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young  may be used one day to treat diabetes, Parkinson's disease, and heart and spinal injuries.

About Bio-Matrix Scientific Group Inc.:

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG) are StemCells Inc. (Nasdaq:STEM) and Cryo-Cell International Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CCEL CCEL Christian Classics Ethereal Library ).

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 20, 2005
Words:343
Previous Article:District Attorney Exonerates Krave Nightclub -- Las Vegas.
Next Article:NicOx Announces Full Patient Enrollment in Phase II Trial of NCX 4016 in PAOD.



Related Articles
Bio-Matrix Scientific Group, Inc. Applies for International Society for Stem Cell Research Membership.
Bio-Matrix Scientific Group to Unveil Its Latest Stem Cell Cryogenic and Tissue Management Technologies at the Financial Services Exchange Conference...
Dr. Geoffrey O'Neill to Lead the Bio-Matrix Scientific Delegation at the Financial Services Exchange Conference in Los Angeles, April 22nd-24th.
Bio-Matrix Scientific Group Sees Its Participation at the Financial Services Exchange Conference as a Huge Success.
Bio-Matrix Scientific's Senior Management Attends Meeting for the California Institute for Regenerative Medicine -- aka: Proposition 71 Stem Cell...
Bio-Matrix Scientific Group Inc. Announces Regenerative Medicine Company Spin-off and Re-Structuring.
Bio-Matrix Scientific to Present Plans for Roll-out of Stem Cell Bank and Instruments at the Financial Services Exchange Conference in Kansas City...
Bio-Matrix Scientific Exhibiting Stem Cell Instruments & Stem Cell Bank at the American Society of Plastic Surgeons Convention in Chicago September...
Cloning scandal exposes fraudulent embryonic stem-cell research.
Bio-Matrix Scientific Group Inc. Attends American Society of Plastic Surgeons Conference Held October 6 - 11 in San Francisco.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles